QA – Page 34 – Pharma.Tips

Shared Facility Risk Matrix for QA and Manufacturing Teams

Addressing Challenges in Shared Facility Risk Management for QA and Manufacturing In a multi-product pharmaceutical facility, maintaining compliance with Good Manufacturing Practices (GMP) while ensuring effective cross-contamination control can present…

How to Assess Patient Risk After Potential Cross-Contamination Event

How to Evaluate Risks Following a Cross-Contamination Incident In the realm of pharmaceutical manufacturing, the potential for cross-contamination presents significant risks both to product integrity and patient safety. A single…

How to Prevent Product Carryover in Shared Equipment Trains

Strategies for Preventing Product Carryover in Shared Manufacturing Equipment Product carryover in shared manufacturing equipment poses a significant risk to pharmaceutical quality and safety. This issue becomes especially critical in…

Cross-Contamination Investigation After Residue Detected in Next Product

Managing Residue Detection: Strategies for Cross-Contamination Investigations In pharmaceutical manufacturing, the detection of residue from one product in the subsequent run can trigger significant concern. This problem may lead to…

Shared Facility Cleaning Validation Requirements for GMP Compliance

Addressing Cleaning Validation Challenges in Shared Pharmaceutical Facilities Shared facilities present unique challenges in the context of cleaning validation, particularly when it comes to ensuring compliance with Good Manufacturing Practices…

Cleaning Deviation vs Cross-Contamination Deviation: How to Classify Correctly

How to Properly Classify Cleaning Deviation and Cross-Contamination Deviation In the pharmaceutical industry, deviations in cleaning protocols and cross-contamination events pose significant risks to product quality and regulatory compliance. Understanding…

Risk-Based Segregation Strategy for Shared Manufacturing Areas

Implementing Effective Risk-Based Segregation in Shared Manufacturing Areas In the realm of pharmaceutical manufacturing, shared facilities pose significant risks for contamination and cross-contamination. Pharmaceutical professionals must navigate these challenges carefully…

How to Prevent Cross-Contamination During Product Changeover Cleaning

Strategies to Mitigate Cross-Contamination During Product Changeover Cleaning Cross-contamination during product changeover cleaning poses significant risks to pharmaceutical manufacturing environments. Inadequate cleaning processes can lead to contamination of products, affecting…

How to Use HBEL and PDE in Shared Facility Risk Assessment

Implementing Risk Management Strategies in Shared Facilities Using HBEL and PDE In the landscape of pharmaceutical manufacturing, shared facility environments pose a unique set of risks, particularly when it comes…

Cleaning and Cross-Contamination Risk Assessment for Shared Equipment

Assessment and Management of Cleaning and Cross-Contamination Risks in Shared Pharmaceutical Equipment In pharmaceutical manufacturing, the risk of cleaning and cross-contamination deviations poses significant challenges, especially when using shared equipment.…

Shared Facility Controls for Potent APIs and Hormonal Products

Effective Strategies for Managing Risks in Shared Pharmaceutical Facilities In the landscape of pharmaceutical manufacturing, shared facility environments pose substantial risks, especially when dealing with potent active pharmaceutical ingredients (APIs)…

Cross-Contamination Deviation Case Study: Product Residue Found After Cleaning

Addressing Product Residue Findings Post-Cleaning: A Cross-Contamination Case Study In an increasingly regulated pharmaceutical environment, cross-contamination must be a top priority for manufacturers. A common indicator of potential issues arises…